0001628280-21-014731.txt : 20210728
0001628280-21-014731.hdr.sgml : 20210728
20210728163001
ACCESSION NUMBER: 0001628280-21-014731
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210726
FILED AS OF DATE: 20210728
DATE AS OF CHANGE: 20210728
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casdin Eli
CENTRAL INDEX KEY: 0001534264
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40646
FILM NUMBER: 211122879
MAIL ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 1140
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Absci Corp
CENTRAL INDEX KEY: 0001672688
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 453931977
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18105 SE MILL PLAIN BLVD
CITY: VANCOUVER
STATE: WA
ZIP: 98683
BUSINESS PHONE: (360) 949-1041
MAIL ADDRESS:
STREET 1: 18105 SE MILL PLAIN BLVD
CITY: VANCOUVER
STATE: WA
ZIP: 98683
FORMER COMPANY:
FORMER CONFORMED NAME: AbSci Corp
DATE OF NAME CHANGE: 20201026
FORMER COMPANY:
FORMER CONFORMED NAME: AbSci, Inc.
DATE OF NAME CHANGE: 20201026
FORMER COMPANY:
FORMER CONFORMED NAME: AbSci, LLC
DATE OF NAME CHANGE: 20160420
4
1
wf-form4_162750417875070.xml
FORM 4
X0306
4
2021-07-26
0
0001672688
Absci Corp
ABSI
0001534264
Casdin Eli
C/O ABSCI CORPORATION
18105 SE MILL PLAIN BLVD
VANCOUVER
WA
98683
1
0
0
0
Common Stock
2021-07-26
4
C
0
4209573
A
4209573
I
See footnote
Common Stock
2021-07-26
4
C
0
973260
A
5182833
I
See footnote
Common Stock
2021-07-26
4
P
0
1562500
16
A
6745333
I
See footnote
Common Stock
2021-07-26
4
C
0
973260
A
973260
I
See footnote
Series E Preferred Stock
2021-07-26
4
C
0
1274431
0
D
Common Stock
4209573.0
0
I
See footnote
Convertible Note
13.12
2021-07-26
4
C
0
12769178
0
D
Common Stock
973260.0
0
I
See footnote
Convertible Note
13.12
2021-07-26
4
C
0
12769178
0
D
Common Stock
973260.0
0
I
See footnote
These shares of the Series E Preferred Stock automatically converted on a one-for-3.3031 basis into the number of shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), shown in Column 7 immediately upon closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series E Preferred Stock had no expiration date.
These shares are held by Casdin Partners Master Fund, L.P. Casdin Capital, LLC ("Casdin Capital") is the investment adviser to Casdin Partners Master Fund, L.P., and Casdin Partners GP, LLC ("Casdin Partners GP") is the general partner of Casdin Partners Master Fund, L.P. Eli Casdin is the managing member of Casdin Capital and Casdin Partners GP. Each of Casdin Capital, Casdin Partners GP and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein, if any.
This convertible promissory note ("Convertible Note") had a maturity date of September 16, 2023. The principal and accrued interest under the Convertible Note converted upon the closing of the IPO into shares of Common Stock at a conversion price equal to $13.12 per share without payment of additional consideration.
These shares are held by Casdin Private Growth Equity Fund, L.P. Casdin Capital is the investment adviser to Casdin Private Growth Equity Fund, L.P. and Casdin Private Growth Equity Fund GP, LLC ("Casdin Private Growth GP") is the general partner of Casdin Private Growth Equity Fund, L.P. Eli Casdin is the managing member of Casdin Capital and Casdin Private Growth GP. Each of Casdin Capital, Casdin Private Growth GP and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein, if any.
/s/ Eli Casdin
2021-07-28